GLVitamins

Showing posts with label azoospermia. Show all posts
Showing posts with label azoospermia. Show all posts

Sunday, April 1, 2012

Assisted Reproductive Technologies

1) Intracytoplasmic sperm injection is an artificial path shortening of sperm to egg. Sperm is injected directly into uterine cavity which increases chances of successful fertilization. Indications for intracytoplasmic sperm injection:
- ejaculatory dysfunction (breakdown of ejaculation process)
- immunological infertility
- oligozoospermia (low sperm count)

2) In vitro fertilization
In this procedure ovums are taken from female egg after preliminary hormonal stimulation which then are fertilized with male sperm (sperm of husband or donor). Embryos are grown in incubator during 48 – 72 hours, then they are inserted into female alvus. The success of this type of fertilization depends on state of female endocrine system. Frequency of pregnancy is higher in cases where more than 5 eggs were fertilized with sperm.

3) Intra Cytoplasmic Sperm Injection (ICSI)
Chances of azoospermia correction are low. However, today was implemented technique of sperm injection directly in cytoplasm of ovum (ICSI). Here are used singular sperm cells of epididymal (taken from male epididymis) or testicular origin. Indications for ICSI:
  • concentration of sperm cells is less than 10 mil. (2 mil. for ICSI)
  • sperm motility less than 10% (5% for ICSI)
  • more than 70% pathological forms of sperm cells (over 96% for ICSI)
  • opportunity to get sperm cells only surgically
  • failure of other methods of infertility treatment
The effectiveness of artificial insemination techniques is 30% after just one attempt. Using of assisted reproductive technologies do greatly increases facilities of correction of most severe forms of male infertility including azoospermia. Effective treatment of infertility is possible only when urologists, ginecologists and in vitro fertilisation specialists do interact. Patient must be informed enough about modern techniques of infertlity treatment.

Wednesday, March 28, 2012

Treatment of Male Infertility

Obstructive infertility
Obstructive azoospermia is characterized with normal testes size, normal rate of hormones, deficiency of spermatogenesis in ejaculate, genitalia inflammatory diseases, surgery on organs of scrotum and small pelvis, pathology of adnexas and seminiferous paths during palpation.

Optimal treatment for obstructive azoospermia is microsurgical regeneration of seminiferous paths with single-step obtainment of sperm cells from area before barrier. Obtained sperm cells may be used in ISCI (Intra Cytoplasmic Sperm Injection). Here a number of sperm cells undergo cryopreservation (deep freezing) and they are used in extracorporal fertilization in case of unsuccessful surgery.

Secretory infertility
Most complicated problem when using extracorporal fertilization is treatment of patients with secretory (non-obstructive) form of infertility. This form is characterized with signs of hypogonadism, singular sperm cells or spermatogenesis cells in ejaculate, hormonal shifts, genetic and chromosomal changes.

In secretory azoospermia may be preserved partial spermatogenesis. Thus optimal method of getting sperm cells in non-obstructive azoospermia during ISCI is bilateral multifocal testicular biopsy with usage of microsurgical methods. This is an instrumental control of research of spermatogenesis areas which were kept with the help of test centesis of different testicular areas.

Bilateral multifocal testicular biopsy helps to obtain up to 65% of sperm cells. In non-obstructive azoospermia on the back of hypogonadism (low testosterone rate resulted from hypothalamus pathology) it is necessary to undergo stimulation therapy with gonadotropic hormones.

In frank pathospermia on the back of genetic abnormalities, hypogonadism, obstructive semiology, varicocele is used empiric treatment. Combination of non-obstructive azoospermia with antispermal antibodies is contraindicated for performing stimulation therapy.

Tuesday, March 27, 2012

Antisperm Antibody Testing

Investigation of immunological factor of infertility is based on making tests on presence of antisperm antibodies in semen and in blood plasma in patient and his partner. Standard tests are performed:
  • MAR is standard test for detecting percentage of spermatozoids with antisperm antibodies (positive result is 50% of spermatozoids with antibodies);
  • IFA (immunofluorescent assay) detects level of antisperm antibodies in blood plasma in patient and his sexual partner.
Positive results of test prove the immune factor of infertility. When another pathologies are not found, the diagnosis of isolated immune infertility, which is found in 10% of marriages, is made. At this stage may be diagnosed varicocele, obstructive azoospermia, and may be detected group of patients with reduced fertility without specification of ethiology at this stage or immunologic factor of infertility. Results obtained at this stage help to narrow diagnostic algorithm of second stage.

On second stage next tests are performed:
  • identification of hormonal level is required in patients with azoospermia. It detects the rate of testosterone, follicle-stimulating hormones interstitial cell-stimulating hormone and also sex-hormone that binds globulin which shows not only the amount of testosterone but also its biological activity.
  • ultrasound investigation of scrotum organs helps to find structural changes and pathologic growths in testes, adnexas, prostate gland. This test shows changes in seminal vesicles in case of seminiferous paths distal sections blocking or no changes in innate agnesia of spermoduct. Chromatic doppler investigation helps to detect venous hyperemia in the system of spermatic veins and also detects subclinical varicocele.
  • identification of urogenital infections agents is made to see if infertility is caused by infection. Indications for this test are: undetermined character of fertility reduction, recurrent pregnancy loss, and also preparation for additional reproductive techniques. Diagnostics of sexually transmitted infections must be made using immunofluorescent assay together with PCR (polymerase chain reaction).
  • genetic investigations are made in azoospermia. Karyotyping detects abnormalities in chromosome set. Today becomes popular test which investigates AZF-segment of Y-chromosome. Around 10% of non-obstructive azoospermia cases are connected with dropping of one or several locuses in Y-chromosome on AZT-segment. Genetic investigations provide not only data about genes, but also about the chances that the disease may be transmitted to masculine descents.
  • investigations of centrifuged semen and post-orgasmic urine helps to define causes of azoospermia. Investigation of post-orgasmic urine is made in case of retrograde ejaculation.
  • seeding of semen is made in pyospermia, and also in case of bad results of spermogram.